about
Focus on adoptive T cell transfer trials in melanomaChemoimmunotherapy versus chemotherapy for metastatic malignant melanomaChemoimmunotherapy versus chemotherapy for metastatic malignant melanomaLong-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanomaUnexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysisTargeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.Melanoma: Molecular Pathogenesis and Therapeutic ManagementSimultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulinAdjuvant therapy for malignant melanoma.Targeting CD20 in melanoma patients at high risk of disease recurrence.Primary pulmonary melanoma: a report of two cases.Induction of apoptosis by 11-dehydrosinulariolide via mitochondrial dysregulation and ER stress pathways in human melanoma cellsMetronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice.New approaches in metastatic melanoma: biological and molecular targeted therapies.Primary amelanotic malignant melanoma of the small intestine diagnosed by esophagogastroduodenoscopy before surgical resection.Chemotherapy in the management of advanced cutaneous malignant melanoma.A genomic screen identifies TYRO3 as a MITF regulator in melanoma.Current research and development of chemotherapeutic agents for melanomaPrimary malignant melanoma of left lower lobe of lung: A case report and review of the literatureAutophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14.Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line.Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaImmunotherapy of metastatic melanoma using genetically engineered GD2-specific T cellsAlterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.Prolonged survival after surgical resection of cerebral metastasis from melanoma with multisystemic metastasis already present: a case report and literature review.Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.Stage IV melanoma: completely resectable patients are scarce.Primary malignant melanoma of the lung: a case report of a rare tumor and review of the literature.
P2860
Q21328679-1C36C244-5EA5-4CBD-916B-D34452E2741BQ24246409-2B8ADE68-C59A-4A20-9ED7-9ECF7F9ECDA7Q24246853-96A07F46-289D-4D6A-B282-67409DBD1AEAQ24816477-7D241BD4-E26E-415D-B8D3-74B45F24DD44Q33394736-396508EF-DBB9-48EA-A632-D3F11F8C5819Q33556564-0FF0CACA-DE22-4C99-9DBE-062C5964A1F9Q33954883-19199E47-7792-47A8-833E-0DCB4FD90DE1Q34093600-D30C2A57-8B16-4D90-9C51-0BCA82459F30Q34123491-377D4005-555A-461F-88AE-3149B3BC4245Q34170003-5C0D87B3-9BB0-4B9B-8E98-0F98CE961127Q35052161-336F0CA8-0866-470A-9686-AF6187B15C0FQ35137163-D60CB76A-B7F8-4A94-8C14-CE6147D85F10Q35165322-FA168A27-18DC-491B-B101-606EFAD3DA73Q35918453-1CABB3A5-C6E5-44DE-B014-82441F9A6003Q35939451-5094B840-C3C1-4623-A4BD-71ED941DF642Q36069366-337B3B9C-2074-49C0-9E55-A331D0BC316BQ36248410-4EA6838D-9B0E-4D75-A393-F9D3C2FF010DQ36341538-51DF43CA-DE49-4948-9C3D-2E5BB6626B8FQ36589127-2B2850C4-3999-42DC-AC33-AD1A263D1209Q36694876-7DF0D66D-1F7F-458B-A869-BC68AB8F5E5CQ36694941-BE0ADE04-AD9C-4230-BDDE-5FA9F0E80533Q36817127-ACECCB59-E7AD-47CF-BD89-92B708B88813Q36917081-C96994F4-61D7-478E-B140-2EA92252D528Q37007984-2712A558-35C4-48BF-8A53-71354E08B4F4Q37386014-C89D1068-D50B-4961-817F-271601054E41Q38166569-399F938E-6301-48BC-87FA-6588C21F5587Q38546544-1E6F8FA8-6659-47AF-BBE7-1E74B30309B5Q39239290-1CDF7C29-AF90-409F-A745-0422063E3A0BQ39396223-A73D9256-26E9-49C4-B7F3-46ED31BFF1FBQ39740960-586CA9CE-2C5D-4240-9B90-5CDA357C4EB1Q40007423-7C532823-EBAB-4B02-9E9D-DBB57E7F644DQ42557896-C567A49A-DE9D-42AA-AF4B-9FC40167DEFEQ44656396-A42BC00B-52CB-480E-9D35-F4CF4A752136Q45377423-0C96A44D-66F7-446F-BB12-0F7B26269F1AQ46621129-960A024B-6DDE-4019-9E71-A83C61EC87C6Q46648179-7C358BE1-4BE1-4991-A4EA-CE7277E021E2Q48143487-023F5A46-07BC-48E9-BFF4-04D1CFC116ACQ50220559-2CC5A953-7D70-49A5-B9F2-04A7A2CEFB6AQ50873280-1A706A78-B395-482A-8948-F9EE181ED0D5Q55030397-4420E36C-A01A-4A73-996E-BFCAEE18D150
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Metastatic melanoma: chemotherapy.
@ast
Metastatic melanoma: chemotherapy.
@en
Metastatic melanoma: chemotherapy.
@nl
type
label
Metastatic melanoma: chemotherapy.
@ast
Metastatic melanoma: chemotherapy.
@en
Metastatic melanoma: chemotherapy.
@nl
prefLabel
Metastatic melanoma: chemotherapy.
@ast
Metastatic melanoma: chemotherapy.
@en
Metastatic melanoma: chemotherapy.
@nl
P2093
P50
P356
P1433
P1476
Metastatic melanoma: chemotherapy.
@en
P2093
David Khayat
Emilio Bajetta
Paola Nova
Roberto Buzzoni
Sophie Taillibert
Stefania Aglione
P304
P356
10.1053/SONC.2002.35238
P577
2002-10-01T00:00:00Z